Argyrios Ziogas

Argyrios Ziogas is …
instance of (P31):
humanQ5

External links are
P2038ResearchGate profile IDArgyrios_Ziogas

P108employerUniversity of California, IrvineQ868421
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q360214067q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q45978346A comparison study of clinicopathologic characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) patients by smoking status.
Q33747778A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
Q29417084A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
Q37192589A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q46234252A population-based, descriptive analysis of malignant intraductal papillary mucinous neoplasms of the pancreas
Q40657328A resource utilization projection study of EUS.
Q36946511A targeted genetic association study of epithelial ovarian cancer susceptibility
Q33637973A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important
Q27908547A validation method to determine missing years of birth in a cohort study of shipyard workers using social security number
Q46193621Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study
Q33619769Adenomyosis and endometriosis in the California Teachers Study
Q43663669Adherence to treatment guidelines for ovarian cancer as a measure of quality care
Q24812570Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin's lymphoma
Q38406780Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study
Q52647897Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
Q39437211Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers
Q46314406An age-dependent interaction between sex and geographical UV index in melanoma risk
Q46063050An inverse association between ovarian cysts and breast cancer in the breast cancer family registry
Q36831854Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome
Q45948722Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry.
Q53379714Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status.
Q46851695Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates
Q37584843Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium
Q34613673Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Q30276986Assessing the genetic architecture of epithelial ovarian cancer histological subtypes
Q37684409Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q33828680Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival
Q24619808Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Q46006754Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults.
Q37200998Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study
Q39423088Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study
Q37403674Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival
Q35022847Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
Q35532898Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Q57056093Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
Q37640500Attitudes Toward Cancer Clinical Trial Participation in Young Adults with a History of Cancer and a Healthy College Student Sample: A Preliminary Investigation
Q46002468Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types.
Q39642676Breast cancer risk and methylenetetrahydrofolate reductase polymorphism
Q46138590Breast cancer survival and hormone replacement therapy: a cohort analysis
Q36449203CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer
Q50915196Cancer burden in four countries of the Middle East Cancer Consortium (Cyprus; Jordan; Israel; Izmir (Turkey)) with comparison to the United States surveillance; epidemiology and end results program.
Q33833595Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer
Q38627972Cancer risk in different generations of Middle Eastern immigrants to California, 1988-2013.
Q41745402Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer
Q46778926Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases
Q35782435Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer
Q46525423Clinical Implementation of a Breast Cancer Risk Assessment Program in a Multiethnic Patient Population: Which Risk Model to Use?
Q36009587Clinically relevant changes in family history of cancer over time
Q37657957Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer
Q35668946Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Q29417145Common variants at 19p13 are associated with susceptibility to ovarian cancer
Q36255665Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q34181322Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer
Q34342248Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q30745400Correlates of vitamin supplement use in the United States: data from the California Teachers Study cohort
Q37158390Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer
Q44775873Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity
Q55115973Diet and predictors of dietary intakes in women with family history of breast and/or ovarian cancer.
Q36168230Diet and risk of ovarian cancer in the California Teachers Study cohort
Q33805341Dietary Risk Factors for Sporadic Creutzfeldt-Jakob Disease: A Confirmatory Case-Control Study
Q46082238Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer
Q36627299Dietary patterns and risk of ovarian cancer in the California Teachers Study cohort
Q46349072Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease
Q33824208ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study
Q24810775Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer
Q44249326Effects of socioeconomic status and treatment disparities in colorectal cancer survival
Q41868438Enhanced Expression of Radiation-induced Leukocyte CDKN1A mRNA in Multiple Primary Breast Cancer Patients: Potential New Marker of Cancer Susceptibility.
Q28282443Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors
Q53591906Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology.
Q24633316Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
Q36487146Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
Q57319395Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer
Q57306046Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium
Q36966218Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study
Q35897406Evaluation of 30-day hospital readmission after surgery for advanced-stage ovarian cancer in a medicare population
Q21144976Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"
Q35653910Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
Q36720821Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
Q38845261Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk
Q46629818Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q36956156GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Q39565188Gene-environment interactions in renal cell carcinoma
Q37739048Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q34378972Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Q28388497Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Q40060942Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study
Q36218993Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q63681757Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Q29417100Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
Q33778612Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
Q33410700Genotype determination for polymorphisms in linkage disequilibrium
Q28146076Germ-line msh6 mutations in colorectal cancer families
Q21195235Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer
Q45236849High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease
Q40060927History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium
Q41115943Human Nail Clippings as a Source of DNA for Genetic Studies
Q34134850Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort
Q46950052Hypertension, diuretics and breast cancer risk
Q37006170Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Q35541663Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q34470171Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival
Q40249992Impact of community disadvantage and air pollution burden on geographic disparities of ovarian cancer survival in California
Q41757407Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California
Q31101650Imputation of missing ages in pedigree data
Q37684424Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration
Q46301216Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988-1995.
Q30277784Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer
Q42997447Korean ethnicity as compared with white ethnicity is an independent favorable prognostic factor for overall survival in non-small cell lung cancer before and after the oral epidermal growth factor receptor tyrosine kinase inhibitor era.
Q37725393Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome
Q46219463Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study
Q46196878Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis
Q35119701Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Q43793910Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status
Q24618839Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X
Q34097339Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study
Q36450416Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis
Q44082151Microsatellite instability in Japanese vs European American patients with gastric cancer
Q36719139Microvascular breast reconstruction in the diabetic patient
Q34123806Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls
Q36551503Mortality risk after preoperative versus postoperative chemotherapy and radiotherapy in lymph node-positive rectal cancer
Q36015876Multilevel socioeconomic effects on quality of life in adolescent and young adult survivors of leukemia and lymphoma
Q36897003Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Q46659535Negative Valence Life Events Promote Breast Cancer Development
Q26799669Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk
Q37356243Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Q30275832No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival
Q28176257Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status
Q34432899Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis
Q35892049Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study
Q37378287Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium
Q36027025Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
Q37486444Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer
Q33973395Ocular Tonometry and Sporadic Creutzfeldt - Jakob Disease (sCJD): A Confirmatory Case-Control Study
Q34398269Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations
Q46355918Outcomes of bariatric surgery performed at accredited vs nonaccredited centers
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q46147249Physical activity and colon cancer risk among women in the California Teachers Study
Q40798938Pilot study of blood biomarker candidates for detection of pancreatic cancer
Q45073049Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: Evidence from the Ovarian Cancer Association Consortium
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q33891803Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium
Q24648412Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women
Q36066735Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
Q33921008Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium
Q35899433Population-based evaluation of adenosquamous carcinoma of the colon and rectum
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q45985998Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung.
Q51667280Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
Q46634553Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.
Q45985654Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size.
Q35223068Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer
Q34958895Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling
Q30448634R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression
Q46016968Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.
Q52759419Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.
Q53698034Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.
Q46351229Recruitment strategies for cervical cancer prevention study
Q35155449Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Q46060490Regional variations in breast cancer among california teachers
Q39705133Residential mobility in the California Teachers Study: implications for geographic differences in disease rates
Q46338113Residential proximity to agricultural pesticide use and incidence of breast cancer in the California Teachers Study cohort
Q39326953Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci
Q46019480Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival.
Q37300024Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Q37624504Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10
Q35749402Risk of second primary cancer in men with breast cancer
Q38716934Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence
Q33669034Role of primary tumor resection among chemotherapy-treated patients with synchronous stage IV colorectal cancer: a survival analysis
Q33310470Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis
Q44781581Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women
Q38835179Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light exposure
Q36089391Shared genetics underlying epidemiological association between endometriosis and ovarian cancer
Q61118451Shared heritability and functional enrichment across six solid cancers
Q64004349Shared heritability and functional enrichment across six solid cancers
Q37151786Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer
Q37515856Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines
Q34002907Socioeconomic Impacts on Survival Differ by Race/Ethnicity among Adolescents and Young Adults with Non-Hodgkin's Lymphoma
Q37486453Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer
Q30583547Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status
Q37337219Survival after colorectal cancer diagnosis is associated with colorectal cancer family history
Q46034086Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment.
Q46134121Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules
Q33703793Survival of distinct Asian groups among colorectal cancer cases in California
Q24806109The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer
Q38461745The Cancer Genetics Network: recruitment results and pilot studies
Q35268940The association between circulating total folate and folate vitamers with overall survival after postmenopausal breast cancer diagnosis
Q50709318The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies.
Q35636609The association of body mass index with mortality in the California Teachers Study
Q35558999The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort
Q36836192The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial
Q35024008The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing
Q36142060The role of genetic breast cancer susceptibility variants as prognostic factors
Q43658255Timing of radiation therapy, lymph node retrieval, and survival in rectal cancer
Q40782001Treatment for T1a Renal Cancer Substratified by Size: "Less is More".
Q46080721Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ
Q46289740Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis
Q37081074Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium
Q30766723Validation of family history data in cancer family registries
Q31140446Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry
Q36711004Validity of models for predicting BRCA1 and BRCA2 mutations
Q56342454Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility
Q33847791Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer
Q35575288Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort
Q41672358Young age as a prognostic factor in cervical cancer: results of a population-based study
Q56334023rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

Search more.